Healthcare shares are fairly flat in pre-market trade.
In healthcare stocks news, shares of McKesson Corp (
) are up 7% at $152.99 after the company signed an agreement to
acquire a majority stake in German company Celesio for $8.3
billion. Separately, the company posted FQ2 EPS of $2.27 on revenue
of $33 billion, beating Capital IQ estimates for $2.04 in EPS on
$32 billion in revenue.
And, Celgene Corporation (
) reported Q3 2013 total revenue of $1.674 billion compared to
$1.419 billion in Q3 2012. For the same period, adjusted diluted
earnings per share (
) increased 21% to $1.56 from $1.29.
Analysts expected $1.53 in earnings for Q3 and revenue of $1.63
bln, according to Capital IQ.
CELG is up 2% at $163.45, a new 52-week high. For 2013, Celgene
expects $5.90 to $5.95, straddling the $5.94 per share the Street
expects, according to Capital IQ estimates.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.